MJ Biz report
Denmark’s trial scheme for medical cannabis will be extended beyond the end of 2021, when the temporary program had been set to expire, the country’s Ministry of Health announced Tuesday.
The trial gives doctors the ability to prescribe cannabis to patients and appropriately licensed businesses the ability to grow and ship medical marijuana.
A majority of parliamentary parties agreed to make permanent the ability for businesses to grow cannabis for medical use – a welcome move for companies such as Alberta-based Aurora Cannabis, which still operates a production subsidiary in Denmark.
Read full article at
